Arthritis Rx: A Cutting-Edge Program for a Pain-Free Life
Description:
Arthritis does not have to mean a lifetime of prescription medications or debilitating pain. Dr. Vijay Vad, who has been on the cutting edge of arthritis research and treats many of today’s star athletes, has developed a proven system for easing arthritis through lifestyle changes.
A revolutionary three-part approach, the Arthritis Rx Plan details:
• The best nutritional and other supplements for managing arthritis
• The Arthritis Rx Diet—including an anti-inflammatory nutrition plan and a sample week with meals, recipes, and exercises
• The Arthritis Rx exercises—three step-by-step exercise series, ranging from a gentle motion regimen to a strenuous core body workout, all demonstrated through over 100 precise photographs.
Dr. Vad’s patients are proof: In just fifteen minutes a day for eight weeks, tremendous healing and joint strengthening can occur using the exercises in combination with the Arthritis Rx nutrition and supplement plan. For the more than 43 million Americans battling this debilitating ailment, Arthritis Rx is a breakthrough prescription.
Best prices to buy, sell, or rent ISBN 9781592402748
Frequently Asked Questions about Arthritis Rx: A Cutting-Edge Program for a Pain-Free Life
The price for the book starts from $5.77 on Amazon and is available from 33 sellers at the moment.
If you’re interested in selling back the Arthritis Rx: A Cutting-Edge Program for a Pain-Free Life book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Arthritis Rx: A Cutting-Edge Program for a Pain-Free Life book, the best buyback offer comes from and is $ for the book in good condition.
The Arthritis Rx: A Cutting-Edge Program for a Pain-Free Life book is in very low demand now as the rank for the book is 2,031,663 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.